Pierluigi Scalia

1.9k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Pierluigi Scalia is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Pierluigi Scalia has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in Pierluigi Scalia's work include Metabolism, Diabetes, and Cancer (10 papers), Ubiquitin and proteasome pathways (7 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Pierluigi Scalia is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Ubiquitin and proteasome pathways (7 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Pierluigi Scalia collaborates with scholars based in United States, Italy and Australia. Pierluigi Scalia's co-authors include Riccardo Vigneri, Giuseppe Pandini, Francesco Frasca, Laura Sciacca, Ira D. Goldfine, Angela Costantino, Rossana Mineo, Antonino Belfiore, Rizwan Masood and D. Lynne Smith and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Pierluigi Scalia

25 papers receiving 1.4k citations

Hit Papers

Insulin Receptor Isoform A, a Newly Recognized, High-Affi... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierluigi Scalia United States 13 996 687 330 283 241 26 1.5k
Kathleen Haugk United States 13 633 0.6× 291 0.4× 274 0.8× 121 0.4× 202 0.8× 15 1.3k
Magali Irla France 22 357 0.4× 152 0.2× 162 0.5× 211 0.7× 152 0.6× 46 1.4k
Emily S. Venanzi United States 9 358 0.4× 895 1.3× 54 0.2× 249 0.9× 758 3.1× 10 2.7k
A. Nawa Japan 21 461 0.5× 47 0.1× 170 0.5× 385 1.4× 171 0.7× 30 1.3k
Ditte Tornehave Denmark 16 387 0.4× 230 0.3× 56 0.2× 118 0.4× 221 0.9× 30 1.0k
Shanli Tsui United States 16 439 0.4× 401 0.6× 83 0.3× 194 0.7× 249 1.0× 19 1.3k
Jacques‐Emmanuel Guidotti France 18 697 0.7× 59 0.1× 88 0.3× 111 0.4× 302 1.3× 34 1.4k
Nigel Sharfe Canada 19 570 0.6× 65 0.1× 137 0.4× 278 1.0× 337 1.4× 33 1.7k
Jon Kuniyoshi United States 10 335 0.3× 247 0.4× 70 0.2× 201 0.7× 126 0.5× 11 922
Tania Benatar Canada 16 465 0.5× 95 0.1× 260 0.8× 174 0.6× 64 0.3× 29 897

Countries citing papers authored by Pierluigi Scalia

Since Specialization
Citations

This map shows the geographic impact of Pierluigi Scalia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierluigi Scalia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierluigi Scalia more than expected).

Fields of papers citing papers by Pierluigi Scalia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierluigi Scalia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierluigi Scalia. The network helps show where Pierluigi Scalia may publish in the future.

Co-authorship network of co-authors of Pierluigi Scalia

This figure shows the co-authorship network connecting the top 25 collaborators of Pierluigi Scalia. A scholar is included among the top collaborators of Pierluigi Scalia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierluigi Scalia. Pierluigi Scalia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scalia, Pierluigi & Stephen J. Williams. (2023). A Post-translational Modification–enhanced Pull-down Method to Study Degron Domains and the Associated Protein Degradation Complexes. BIO-PROTOCOL. 13(18). e4816–e4816. 1 indexed citations
2.
Scalia, Pierluigi, Stephen J. Williams, Antonio Suma, & Vincenzo Carnevale. (2023). The DTX Protein Family: An Emerging Set of E3 Ubiquitin Ligases in Cancer. Cells. 12(13). 1680–1680. 6 indexed citations
3.
Scalia, Pierluigi & Stephen J. Williams. (2023). Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?. Frontiers in Oncology. 13. 1278402–1278402. 1 indexed citations
4.
Scalia, Pierluigi, Carmen Merali, Carlos A. Barrero, et al.. (2023). Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IRA Signal in Malignant Mesothelioma. International Journal of Molecular Sciences. 24(8). 7380–7380. 5 indexed citations
5.
Scalia, Pierluigi. (2021). Prevalence of Tobacco Use. 13(7). 1–1.
6.
Scalia, Pierluigi, et al.. (2021). Transcriptional and Post-Translational Control Mechanisms for EphB4 Expression in Physiology and Cancer Disease. Critical Reviews in Eukaryotic Gene Expression. 31(2). 83–88. 3 indexed citations
7.
Scalia, Pierluigi, Giuseppe Pandini, Vincenzo Carnevale, Antonio Giordano, & Stephen J. Williams. (2021). Correction: Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma. Oncogene. 40(8). 1551–1551. 1 indexed citations
8.
Scalia, Pierluigi, Antonio Giordano, & Stephen J. Williams. (2020). The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives. Cancers. 12(2). 366–366. 23 indexed citations
9.
Scalia, Pierluigi, Antonio Giordano, Caroline Martini, & Stephen J. Williams. (2020). Isoform- and Paralog-Switching in IR-Signaling: When Diabetes Opens the Gates to Cancer. Biomolecules. 10(12). 1617–1617. 9 indexed citations
10.
Scalia, Pierluigi. (2020). An Expert Patients-for-Patients integrated Biobanking-CRO Operational Model for Sustainable Personalized Oncology. Biomedical Journal of Scientific & Technical Research. 26(3). 1 indexed citations
11.
Scalia, Pierluigi, Giuseppe Pandini, Vincenzo Carnevale, Antonio Giordano, & Stephen J. Williams. (2019). Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma. Oncogene. 38(31). 5987–6001. 14 indexed citations
12.
Decaro, Nicola, Gabriella Elia, Vito Martella, et al.. (2005). Characterisation of the canine parvovirus type 2 variants using minor groove binder probe technology. Journal of Virological Methods. 133(1). 92–99. 112 indexed citations
13.
Sinha, Uttam K., et al.. (2003). Expression of EphB4 in Head and Neck Squamous Cell Carcinoma. Ear Nose & Throat Journal. 82(11). 866–887. 24 indexed citations
14.
Masood, Rizwan, Sutao Zhu, Guangbin Xia, et al.. (2003). Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops. International Journal of Cancer. 104(5). 603–610. 113 indexed citations
15.
Scalia, Pierluigi, et al.. (2002). The Cell Cycle Regulatory Factor TAF1 Stimulates Ribosomal DNA Transcription by Binding to the Activator UBF. Current Biology. 12(24). 2142–2146. 31 indexed citations
16.
Scalia, Pierluigi, Emma Heart, Lucio Comai, Riccardo Vigneri, & Chin K. Sung. (2001). Regulation of the Akt/Glycogen synthase kinase‐3 axis by insulin‐like growth factor‐II via activation of the human insulin receptor isoform‐A. Journal of Cellular Biochemistry. 82(4). 610–618. 23 indexed citations
17.
Frasca, Francesco, Giuseppe Pandini, Pierluigi Scalia, et al.. (1999). Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells. Molecular and Cellular Biology. 19(5). 3278–3288. 724 indexed citations breakdown →
18.
Sciacca, Laura, Angela Costantino, Giuseppe Pandini, et al.. (1999). Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene. 18(15). 2471–2479. 228 indexed citations
19.
Sung, Chin K., Woo Sung Choi, & Pierluigi Scalia. (1998). Insulin-Stimulated Glycogen Synthesis in Cultured Hepatoma Cells: Differential Effects of Inhibitors of Insulin Signaling Molecules. Journal of Receptors and Signal Transduction. 18(4-6). 243–263. 14 indexed citations
20.
Pezzino, V., Vincenzo Papa, G Milazzo, et al.. (1996). Insulin‐like Growth Factor‐I (IGF‐I) Receptors in Breast Cancer. Annals of the New York Academy of Sciences. 784(1). 189–201. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026